| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |